Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
What happens if something goes wrong
You can request dose adjustments, report side effects, or ask questions about nutrition and exercise
Your first dose (semaglutide 0.25 mg or tirzepatide 2.5 mg) is low, but it is a meaningful first step
After a four-week gap, clinicians may advise restarting at the initial 0.25 mg dose depending on the patient's tolerance and prior experience
What we know from animal studies: In rodent studies, tirzepatide caused thyroid C-cell tumors These tumors included both benign and malignant (cancerous) forms Rodents are more susceptible to these tumors than humans The relevance of rodent thyroid findings to humans is unknown What we know from human studies: Clinical trials up to 2 years have not shown increased cancer rates Post-marketing surveillance continues to monitor for cancer signals No medullary thyroid carcinoma cases attributed to Mounjaro in trials The mechanism that causes rodent thyroid tumors may not occur in humans Mounjaro Thyroid Warning: Who Should Not Take This Medication Due to the thyroid tumor findings in animals, Mounjaro carries a boxed warning the FDAs most serious warning type
Understanding your specific peptide amino acid composition helps you predict its storage behavior
